US4179565A - 2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and precursors thereof - Google Patents
2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and precursors thereof Download PDFInfo
- Publication number
- US4179565A US4179565A US05/871,653 US87165378A US4179565A US 4179565 A US4179565 A US 4179565A US 87165378 A US87165378 A US 87165378A US 4179565 A US4179565 A US 4179565A
- Authority
- US
- United States
- Prior art keywords
- benzo
- dimethyl
- thienylmethyl
- tetrahydropyridine
- morphan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Definitions
- the present invention relates to the preparation of 2,5-dimethyl-benzo[b]thieno[2,3-f]morphan (I) to the preparation of two of its intermediates, 2-(3-benzo[b]thienylmethyl)-1,4-dimethyl-1,2,3,6-tetrahydropyridine (II) and 2-(3-benzo[b]thienylmethyl)-1,4-dimethyl-1,2,5,6-tetrahydropyridine (III) and the addition salts thereof with pharmacologically acceptable acids.
- the organic layer gives a mixture from which 2-(3-benzo[b]-thienylmethyl)-1,4-dimethyl-1,2,3,6-tetrahydropyridine (II) and 2-(3-benzo[b]-thienylmethyl)-1,4-dimethyl-1,2,5,6-tetrahydropyridine (III) are separated by distillation and subsequent fractional crystallisation of the corresponding picrates.
- the previously obtained raw mixture is heated to 135° C. for 12 h. in the presence of a strong acid, for example 48% aqueous hydrobromic acid. It is poured over ice and water, rendered alkaline with ammonium hydroxide and extracted with ether, yielding 2,5-dimethyl-benzo[b]thieno[2,3-f]-morphan (I).
- a strong acid for example 48% aqueous hydrobromic acid. It is poured over ice and water, rendered alkaline with ammonium hydroxide and extracted with ether, yielding 2,5-dimethyl-benzo[b]thieno[2,3-f]-morphan (I).
- the column of the reactor is packed with 70 gr. of magnesium in chips, alternating with thin layers of mercuric chloride, and is covered with a saturated solution of mercuric chloride in anhydrous ether. It is left standing for 48 h., 250 ml. of anhydrous ether then being placed in the flask and refluxed for 2 h.
- the flask is replaced by another provided with mechanical stirring, in which 19 gr. of 1,4-dimethylpyridinium iodide in suspension with 300 ml.
- the thermal analgesic effect was studied on I.C.R. Swiss albino mice.
- the hot plate technique was used at 55° C. Batches of 10 mice were made.
- mice were administered intraperitoneally and after 30 minutes the mice were placed on the hot plate, counting the number of seconds they took to jump. Batches of control animals which are only injected with distilled water are used.
- Product I has analgesic activity which is not significantly different from that of dextropropoxyphene.
- Product II is lacking thermal analgesic activity.
- Product III is lacking thermal analgesic activity.
- mice The analgesic effect was studied on I.C.R. Swiss albino mice with the acetic acid writhing technique. Batches of 10 mice were made.
- the products under study were administered intraperitoneally and after 30 minutes 0.25 ml of 1% acetic acid are injected intraperitoneally.
- a batch of control animals which only receive acetic acid is used.
- the number of writhes in each mouse is counted 20 minutes after administration of the acetic acid.
- Product I has greater analgesic activity then dextropropoxyphene.
- the analgesic activity of product II is not significantly different from that of dextropropoxyphene.
- the analgesic activity of product III is not significantly different from that of dextropropoxyphene.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES456283A ES456283A1 (es) | 1977-02-25 | 1977-02-25 | Un procedimiento para la obetencion de 2,5-dimetil-benzo (b)tieno (2,3-f) morfano. |
ES456.283 | 1977-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
US4179565A true US4179565A (en) | 1979-12-18 |
Family
ID=8473232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US05/871,653 Expired - Lifetime US4179565A (en) | 1977-02-25 | 1978-01-23 | 2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and precursors thereof |
Country Status (11)
Country | Link |
---|---|
US (1) | US4179565A (de) |
JP (1) | JPS53137999A (de) |
AR (1) | AR213560A1 (de) |
AT (1) | AT357273B (de) |
BE (1) | BE863266A (de) |
DE (1) | DE2807077C3 (de) |
ES (1) | ES456283A1 (de) |
FR (1) | FR2381772A1 (de) |
GB (1) | GB1574257A (de) |
NL (1) | NL7801992A (de) |
PT (1) | PT67701B (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281130A (en) * | 1979-05-24 | 1981-07-28 | Sterling Drug Inc. | Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate |
US4496572A (en) * | 1981-08-26 | 1985-01-29 | Pfizer Inc. | Benzo-fused thromboxane synthetase inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3382249A (en) * | 1964-10-20 | 1968-05-07 | Sterling Drug Inc | 1, 2, 3, 4, 5, 6-hexahydro-3-(cycloalkyl-lower alkylene-)-2, 6-methano-3-naphth [2, 1-f]azocines |
-
1977
- 1977-02-25 ES ES456283A patent/ES456283A1/es not_active Expired
-
1978
- 1978-01-23 US US05/871,653 patent/US4179565A/en not_active Expired - Lifetime
- 1978-01-24 BE BE184598A patent/BE863266A/xx unknown
- 1978-01-26 FR FR7802216A patent/FR2381772A1/fr not_active Withdrawn
- 1978-01-27 AR AR270881A patent/AR213560A1/es active
- 1978-02-08 GB GB5118/78A patent/GB1574257A/en not_active Expired
- 1978-02-17 AT AT118678A patent/AT357273B/de not_active IP Right Cessation
- 1978-02-17 JP JP1667478A patent/JPS53137999A/ja active Pending
- 1978-02-18 DE DE2807077A patent/DE2807077C3/de not_active Expired
- 1978-02-22 NL NL7801992A patent/NL7801992A/xx not_active Application Discontinuation
- 1978-02-23 PT PT67701A patent/PT67701B/pt unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3382249A (en) * | 1964-10-20 | 1968-05-07 | Sterling Drug Inc | 1, 2, 3, 4, 5, 6-hexahydro-3-(cycloalkyl-lower alkylene-)-2, 6-methano-3-naphth [2, 1-f]azocines |
Non-Patent Citations (2)
Title |
---|
Montzka, T., et al., J. Het. Chem., 11, 853-855, (1974). * |
Perry, R., et al., J. Med. Chem., 10, 1184-1186, (1967). * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281130A (en) * | 1979-05-24 | 1981-07-28 | Sterling Drug Inc. | Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate |
US4496572A (en) * | 1981-08-26 | 1985-01-29 | Pfizer Inc. | Benzo-fused thromboxane synthetase inhibitors |
US4590200A (en) * | 1981-08-26 | 1986-05-20 | Pfizer Inc. | Naphthalene thromboxane synthetase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
DE2807077B2 (de) | 1979-10-31 |
BE863266A (fr) | 1978-05-16 |
ES456283A1 (es) | 1978-04-01 |
AT357273B (de) | 1980-06-25 |
NL7801992A (nl) | 1978-08-29 |
ATA118678A (de) | 1979-11-15 |
PT67701A (en) | 1978-03-01 |
GB1574257A (en) | 1980-09-03 |
DE2807077A1 (de) | 1978-08-31 |
JPS53137999A (en) | 1978-12-01 |
AR213560A1 (es) | 1979-02-15 |
FR2381772A1 (fr) | 1978-09-22 |
DE2807077C3 (de) | 1980-07-10 |
PT67701B (en) | 1980-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6026782B2 (ja) | 新規アリ−ルピペリジン誘導体の製造方法 | |
RU2160731C2 (ru) | Промежуточные продукты для получения 1-бензил-4-((5,6-диметокси-1-инданон)-2-ил)-метилпиперидина, способы их получения и способ получения 1-бензил-4-((5,6-диметокси-1-инданон)-2-ил)-метилпиперидина с их применением | |
US4198417A (en) | Phenoxyphenylpiperidines | |
FR2582309A1 (fr) | Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant | |
US4284635A (en) | Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines | |
US4179565A (en) | 2,5-Dimethyl-benzo[b]-thieno[2,3-f]morphan and precursors thereof | |
US4172201A (en) | Alpha-2,5,9-trimethyl-benzo(b)thiene(2,3-f)morphan and precursor thereof | |
US4178450A (en) | 2,5-Dimethyl-benzo(b) thiene (3,2-f) morphan and precursor thereof | |
OHNO et al. | Synthesis of asymmetric 4-aryl-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridinedicarboxylates with vasodilating and antihypertensive activities | |
US4174396A (en) | 7,10-Dimethyl-5,9-imino-4,5,8,9-tetrahydro-cyclooct[b]thiophenes and a process for obtaining it | |
US4173705A (en) | 2-(2-Furoyl)-4-methylpyridine and its methyl iodide quaternary salt | |
US4145424A (en) | 1,4,4A-Trimethyl-1,2,4a,-4b,9a,10a-hexahydro-10H-benzo b! thieno 2',3':4,3!cyclopent- 1,2-b!-pyridine | |
US3055888A (en) | 2-alkylmercapto-9-[2'-(n-alkylpiperidyl-2" and pyrrolidyl-2")-ethylidene-1']-thiaxanthenes | |
US4247697A (en) | 3-Phenoxy morphinans and their derivatives | |
US4000283A (en) | Compound 3,4,5-trimethoxyphenyl-(3,4-dimethyl-2-pyridyl)-carbonyl | |
US4194044A (en) | Process for preparing 3-phenoxy morphinans | |
US4111945A (en) | Process for the preparation of 3,4,5-trimethoxy-phenyl-(1,4-dimethyl-1,2,3,6-tetrahydro-2-pyridyl)-carbinol | |
US4174451A (en) | 2-Furyl-(3,4-dimethyl-2-pyridyl)-carbinol | |
US3962257A (en) | 3-phenacylpiperidines | |
US4814330A (en) | 3-phenyl-1-propanones, process of preparing thereof and method of treating arrhythmias | |
US2485662A (en) | Alpha-(aminoalkyl)-stilbenes | |
GB1582688A (en) | 7,10-dimethyl-5,9-imino-4,5,8,9-tetrahydro-cycloocta(b)-thiophenes | |
US4228288A (en) | Certain substituted 3,4,5,6-tetrahydropyridinium salt intermediates | |
US4007179A (en) | Oxoindanylpropionic acids and process for the preparation thereof | |
GB1574514A (en) | 2,5-dimethyl-thieno(2,3-f)morphane and a process for obtaining it |